Atlas Trials

Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients

Clinical trial NCT00874289 · COMPLETED

Trial details

NCT number
NCT00874289
Sponsor
The Alfred
Status
COMPLETED
Study type
OBSERVATIONAL
Heart Failure
Start date
2008-12-01
Primary completion
2014-05-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.